Monday, November 18, 2024
- 10:30AM-12:30PM
-
Abstract Number: 1961
Salivary and Lacrimal Glands Ultrasonography in Systemic Lupus Erythematosus Patients
Imaging of Rheumatic Diseases Poster II- 10:30AM-12:30PM
-
Abstract Number: 2033
Scleritis and the Rheumatologist. Does the Type of Scleritis Help to Distinguish an Infectious Cause from an Immune Cause? Among the Immune Causes, Does It Help Differentiate Between Systemic Causes and Those Limited to the Eye?
Miscellaneous Rheumatic & Inflammatory Diseases Poster III- 10:30AM-12:30PM
-
Abstract Number: 2344
Secukinumab Retention and Effectiveness in Patients with Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: 5-year Final Results of a Prospective Real-world Study
SpA Including PsA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 1786
Select Immune Cell Dysregulation Identifies Clinically Quiescent Patients at Risk of Flare Who Stop Mycophenolate Mofetil While Continuing Hydroxychloroquine
SLE – Etiology & Pathogenesis Poster- 10:30AM-12:30PM
-
Abstract Number: 1849
Selective Targeting of One-Carbon Metabolism to Combat Rheumatoid Arthritis
T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster- 10:30AM-12:30PM
-
Abstract Number: 2071
Self-Efficacy Contributes to Better Health Outcomes in Patients of Idiopathic Inflammatory Myopathies: Insights from the COVAD 3 Dataset
Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III- 10:30AM-12:30PM
-
Abstract Number: 2433
Sequential Pneumococcal Vaccination in SLE: Immunogenicity, Side Effects and Comparison with PPSV23 Vaccination
SLE – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 2212
Seropositive Arthralgias: A Comprehensive Analysis of the Reuma-Check Cohort
RA – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2314
Serum Calprotectin (S100A8/9) and Complement Factor C3 as Potential Inflammatory Markers in Obese and “CRP Negative” Early PsA Patients: Data from a Multicenter METAPSA Cohort
SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2063
Serum Glutamate Dehydrogenase in Idiopathic Inflammatory Myopathy Patients
Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III- 10:30AM-12:30PM
-
Abstract Number: 2024
Serum Urate Change Among Patients with Gout Treated with Anti-Hypertensive Medications: A Comparative Effectiveness Analysis
Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster III